|
| TECHNOLOGY |
 |
|
|
|
|
|
|
| 3D printed PDX animal drug screening platform |
Using the multi-channel 3D printing technology platform, on the basis of the existing mature primary tumor cell culture technology, bio-ink is made from biomaterials and patient's tumor cells and printed. Cultivated below. The self-proposed "rapid PDX model" simulates the human in vivo environment through 3D printing technology, expands primary tumor cells, greatly shortens the production cycle of PDX, and at the same time improves the success rate of the model, and can achieve personalized, standardized, Controllable and high-throughput. 40 PDX models have been established, including lung cancer, gastric cancer, bladder cancer and glioma. |
|
|
|
|
|
|
|
Introduction
Using the multi-channel 3D printing technology platform, on the basis of the existing mature primary tumor cell culture technology, bio-ink is made from biomaterials and patient's tumor cells and printed. Cultivated below. The self-proposed "rapid PDX model" simulates the human in vivo environment through 3D printing technology, expands primary tumor cells, greatly shortens the production cycle of PDX, and at the same time improves the success rate of the model, and can achieve personalized, standardized, Controllable and high-throughput. 40 PDX models have been established, including lung cancer, gastric cancer, bladder cancer and glioma.
Technical advantages
Versatile, fast printing
Biomedical Laboratory Professional Edition
Equipped with clinical grade cleaning system
Safe and controllable
Realize the customization of complex and fine structure
Technical Features
Direct or indirect in vitro and in vivo drug screening: highly consistent genetic stability and drug sensitivity, 30-45 days faster than conventional methods
High platform reliability and low investment cost
Construct 3D-PDX model from a small amount of tumor tissue, which can be applied in many aspects
Personalized drug guidance, recurrence monitoring, and prognostic assessment in solid tumors
It can effectively improve the success rate of primary cell culture and the success rate of PDX models, providing more efficient and faster guidance for drug screening in clinical treatment
|
|
|
|
|
|
|
